COLL
Collegium Pharmaceutical, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$35.54-1.50%
Price as of Jul 20, 2026
COLL profitability
Collegium Pharmaceutical, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 60.7%
- EBITDA margin
- 76.6%
- EBIT margin
- 23.8%
- Net margin
- 9.4%
- Free cash flow margin
- 41.4%
Returns
- Return on equity
- 24.0%
- Return on assets
- 4.5%
- Return on invested capital
- 16.9%
- Asset turnover
- 0.48x
Cash efficiency
- Cash from operations
- $331.0M
- Cash per share
- $13
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.